| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NOC3L | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | CNGB3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | TBC1D10A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | GJB3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | EYS | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | SCUBE3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | CCZ1B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | DDX20 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | H2AFJ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TMA16 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
